KEGG   PATHWAY: oor00590
Entry
oor00590                    Pathway                                
Name
Arachidonic acid metabolism - Orcinus orca (killer whale)
Class
Metabolism; Lipid metabolism
Pathway map
oor00590  Arachidonic acid metabolism
oor00590

Other DBs
GO: 0019369
Organism
Orcinus orca (killer whale) [GN:oor]
Gene
101274156  PLA2G3; group 3 secretory phospholipase A2 isoform X1 [KO:K01047] [EC:3.1.1.4]
101285862  group IIE secretory phospholipase A2 isoform X1 [KO:K01047] [EC:3.1.1.4]
101269636  PLA2G12B; group XIIB secretory phospholipase A2-like protein isoform X1 [KO:K01047] [EC:3.1.1.4]
101282600  PLA2G1B; phospholipase A2 [KO:K01047] [EC:3.1.1.4]
101284911  PLA2G12A; group XIIA secretory phospholipase A2 [KO:K01047] [EC:3.1.1.4]
101271114  phospholipase A2 group V isoform X1 [KO:K01047] [EC:3.1.1.4]
101271361  group IID secretory phospholipase A2 [KO:K01047] [EC:3.1.1.4]
101271607  PLA2G2F; LOW QUALITY PROTEIN: group IIF secretory phospholipase A2 [KO:K01047] [EC:3.1.1.4]
101289960  group 10 secretory phospholipase A2 [KO:K01047] [EC:3.1.1.4]
101269805  PLA2G4F; cytosolic phospholipase A2 zeta [KO:K16342] [EC:3.1.1.4]
101270052  PLA2G4E; cytosolic phospholipase A2 epsilon isoform X1 [KO:K16342] [EC:3.1.1.4]
101286206  PLA2G4D; cytosolic phospholipase A2 delta isoform X1 [KO:K16342] [EC:3.1.1.4]
101270543  PLA2G4A; cytosolic phospholipase A2 isoform X1 [KO:K16342] [EC:3.1.1.4]
117195357  PLA2G4B; cytosolic phospholipase A2 beta isoform X1 [KO:K16342] [EC:3.1.1.4]
101277123  PLA2G6; 85/88 kDa calcium-independent phospholipase A2 isoform X3 [KO:K16343] [EC:3.1.1.4]
101277000  PLB1; phospholipase B1, membrane-associated isoform X1 [KO:K14621] [EC:3.1.1.4 3.1.1.5]
101288356  phospholipase A and acyltransferase 3 isoform X2 [KO:K16817] [EC:3.1.1.32 3.1.1.4]
101274585  PTGS1; prostaglandin G/H synthase 1 isoform X1 [KO:K00509] [EC:1.14.99.1]
101270299  PTGS2; prostaglandin G/H synthase 2 [KO:K11987] [EC:1.14.99.1]
101285341  PTGES; prostaglandin E synthase [KO:K15729] [EC:5.3.99.3]
101276928  PTGES2; prostaglandin E synthase 2 isoform X1 [KO:K05309] [EC:5.3.99.3]
101279225  PTGES3; prostaglandin E synthase 3 isoform X2 [KO:K15730] [EC:5.3.99.3]
101289691  carbonyl reductase [NADPH] 1 [KO:K00079] [EC:1.1.1.184 1.1.1.189 1.1.1.197]
101271194  LOW QUALITY PROTEIN: carbonyl reductase [NADPH] 2-like [KO:K00081] [EC:1.1.1.184]
101289932  carbonyl reductase [NADPH] 3 [KO:K00084] [EC:1.1.1.184]
101284921  PRXL2B; prostamide/prostaglandin F synthase isoform X1 [KO:K15717] [EC:1.11.1.20]
101282003  HPGD; 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform X1 [KO:K00069] [EC:1.1.1.141]
101279392  TBXAS1; thromboxane-A synthase isoform X1 [KO:K01832] [EC:5.3.99.5]
101280808  PTGDS; prostaglandin-H2 D-isomerase [KO:K01830] [EC:5.3.99.2]
101285619  HPGDS; hematopoietic prostaglandin D synthase [KO:K04097] [EC:5.3.99.2 2.5.1.18]
101281536  aldo-keto reductase family 1 member C3-like [KO:K04119] [EC:1.1.1.51 1.1.1.188 1.1.1.213 1.1.1.357]
101273575  dihydrodiol dehydrogenase 3 isoform X7 [KO:K04119] [EC:1.1.1.51 1.1.1.188 1.1.1.213 1.1.1.357]
101285307  PTGIS; prostacyclin synthase isoform X4 [KO:K01831] [EC:5.3.99.4]
101283796  ALOX5; polyunsaturated fatty acid 5-lipoxygenase isoform X1 [KO:K00461] [EC:1.13.11.34]
101284157  LTA4H; leukotriene A-4 hydrolase isoform X1 [KO:K01254] [EC:3.3.2.6]
101281851  PTGR3; prostaglandin reductase 3 isoform X1 [KO:K07119] [EC:1.3.1.48]
101277867  PTGR2; prostaglandin reductase 2 isoform X1 [KO:K13949] [EC:1.3.1.48]
101269785  PTGR1; LOW QUALITY PROTEIN: prostaglandin reductase 1 [KO:K13948] [EC:1.3.1.74 1.3.1.48]
101285904  LTC4S; leukotriene C4 synthase [KO:K00807] [EC:4.4.1.20]
101276857  GGT5; glutathione hydrolase 5 proenzyme isoform X1 [KO:K18592] [EC:2.3.2.2 3.4.19.13 3.4.19.14]
101277450  GGT1; glutathione hydrolase 1 proenzyme isoform X6 [KO:K18592] [EC:2.3.2.2 3.4.19.13 3.4.19.14]
101270118  GPX4; phospholipid hydroperoxide glutathione peroxidase isoform X2 [KO:K05361] [EC:1.11.1.12]
101275906  cytochrome P450 2E1 [KO:K07415] [EC:1.14.14.-]
101287985  cytochrome P450 2J2 isoform X1 [KO:K07418] [EC:1.14.14.1 1.14.14.73 1.14.14.74 1.14.14.75]
101288653  cytochrome P450 2U1 isoform X1 [KO:K07422] [EC:1.14.14.80]
101272104  taurochenodeoxycholic 6 alpha-hydroxylase-like [KO:K07425] [EC:1.14.14.80]
101272359  cytochrome P450 4A11-like [KO:K07425] [EC:1.14.14.80]
101283895  taurochenodeoxycholic 6 alpha-hydroxylase-like [KO:K07425] [EC:1.14.14.80]
101279538  ALOX12; polyunsaturated fatty acid lipoxygenase ALOX12 isoform X3 [KO:K00458] [EC:1.13.11.31]
101281475  ALOXE3; LOW QUALITY PROTEIN: hydroperoxide isomerase ALOXE3 [KO:K18684] [EC:4.2.1.152 5.4.4.7]
101281720  polyunsaturated fatty acid lipoxygenase ALOX15B isoform X2 [KO:K08022] [EC:1.13.11.33 1.13.11.-]
101280390  cytochrome P450 2C23-like isoform X1 [KO:K07413] [EC:1.14.14.1]
101281073  LOW QUALITY PROTEIN: cytochrome P450 2C18 [KO:K07413] [EC:1.14.14.1]
101282222  EPHX2; bifunctional epoxide hydrolase 2 isoform X1 [KO:K08726] [EC:3.3.2.10 3.1.3.76]
101281563  ALOX15; LOW QUALITY PROTEIN: polyunsaturated fatty acid lipoxygenase ALOX15 [KO:K00460] [EC:1.13.11.33]
Compound
C00157  Phosphatidylcholine
C00219  Arachidonate
C00427  Prostaglandin H2
C00584  Prostaglandin E2
C00639  Prostaglandin F2alpha
C00696  Prostaglandin D2
C00909  Leukotriene A4
C01312  Prostaglandin I2
C02165  Leukotriene B4
C02166  Leukotriene C4
C02198  Thromboxane A2
C03577  20-Hydroxyleukotriene E4
C04577  15-OxoETE
C04671  (5Z)-11alpha-Hydroxy-9,15-dioxoprostanoate
C04707  (5Z,13E)-11alpha-Hydroxy-9,15-dioxoprost-5,13-dienoate
C04742  (15S)-15-Hydroxy-5,8,11-cis-13-trans-eicosatetraenoate
C04758  (5Z,13E)-9alpha-Hydroxy-11,15-dioxoprosta-5,13-dienoate
C04805  5(S)-HETE
C04822  8(R)-HPETE
C04835  (5Z,13E)-6,9alpha-Epoxy-11alpha-hydroxy-15-oxoprosta-5,13-dienoate
C04853  20-OH-Leukotriene B4
C05356  5(S)-HPETE
C05949  12-Keto-leukotriene B4
C05950  20-COOH-Leukotriene B4
C05951  Leukotriene D4
C05952  Leukotriene E4
C05953  Prostaglandin A2
C05954  Prostaglandin B2
C05955  Prostaglandin C2
C05956  Prostaglandin G2
C05957  Prostaglandin J2
C05958  Delta-12-Prostaglandin J2
C05959  11-epi-Prostaglandin F2alpha
C05960  15-Keto-prostaglandin F2alpha
C05961  6-Keto-prostaglandin F1alpha
C05962  6-Keto-prostaglandin E1
C05963  Thromboxane B2
C05964  11-Dehydro-thromboxane B2
C05965  12(S)-HPETE
C05966  15(S)-HPETE
C06314  Lipoxin A4
C06315  Lipoxin B4
C06462  Leukotriene F4
C13809  9,11,15-Trihydroxy-prosta-5,13-dien-1-oic acid
C14717  15-Deoxy-Delta12,14-PGJ2
C14732  5-OxoETE
C14748  20-HETE
C14749  19(S)-HETE
C14768  5,6-EET
C14769  8,9-EET
C14770  11,12-EET
C14771  14,15-EET
C14772  5,6-DHET
C14773  8,9-DHET
C14774  11,12-DHET
C14775  14,15-DHET
C14776  8(S)-HETE
C14777  12(S)-HETE
C14778  16(R)-HETE
C14779  9(S)-HETE
C14780  11(R)-HETE
C14781  15H-11,12-EETA
C14782  11,12,15-THETA
C14794  2,3-Dinor-8-iso prostaglandin F2alpha
C14795  2,3-Dinor-8-iso prostaglandin F1alpha
C14807  12-OxoETE
C14808  Hepoxilin A3
C14809  Trioxilin A3
C14810  Hepoxilin B3
C14811  Trioxilin B3
C14812  12(R)-HPETE
C14813  11H-14,15-EETA
C14814  11,14,15-THETA
C14815  5,6-Epoxytetraene
C14820  11(R)-HPETE
C14821  9(S)-HPETE
C14822  12(R)-HETE
C14823  8(S)-HPETE
C14824  8(R)-HETE
Reference
  Authors
Spector AA, Fang X, Snyder GD, Weintraub NL.
  Title
Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function.
  Journal
Prog Lipid Res 43:55-90 (2004)
DOI:10.1016/S0163-7827(03)00049-3
Reference
  Authors
Harman CA, Rieke CJ, Garavito RM, Smith WL.
  Title
Crystal structure of arachidonic acid bound to a mutant of prostaglandin endoperoxide H synthase-1 that forms predominantly 11-hydroperoxyeicosatetraenoic acid.
  Journal
J Biol Chem 279:42929-35 (2004)
DOI:10.1074/jbc.M403013200
Reference
  Authors
Poloyac SM, Tortorici MA, Przychodzin DI, Reynolds RB, Xie W, Frye RF, Zemaitis MA.
  Title
The effect of isoniazid on CYP2E1- and CYP4A-mediated hydroxylation of arachidonic acid in the rat liver and kidney.
  Journal
Drug Metab Dispos 32:727-33 (2004)
DOI:10.1124/dmd.32.7.727
Reference
  Authors
Chuang SS, Helvig C, Taimi M, Ramshaw HA, Collop AH, Amad M, White JA, Petkovich M, Jones G, Korczak B.
  Title
CYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes omega- and (omega-1)-hydroxylation of fatty acids.
  Journal
J Biol Chem 279:6305-14 (2004)
DOI:10.1074/jbc.M311830200
Reference
  Authors
Sacerdoti D, Gatta A, McGiff JC.
  Title
Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology.
  Journal
Prostaglandins Other Lipid Mediat 72:51-71 (2003)
DOI:10.1016/S1098-8823(03)00077-7
Reference
  Authors
Pfister SL, Spitzbarth N, Zeldin DC, Lafite P, Mansuy D, Campbell WB.
  Title
Rabbit aorta converts 15-HPETE to trihydroxyeicosatrienoic acids: potential role of cytochrome P450.
  Journal
Arch Biochem Biophys 420:142-52 (2003)
DOI:10.1016/j.abb.2003.09.026
Reference
  Authors
Fleming I.
  Title
Cytochrome p450 and vascular homeostasis.
  Journal
Circ Res 89:753-62 (2001)
DOI:10.1161/hh2101.099268
Reference
  Authors
Qu W, Bradbury JA, Tsao CC, Maronpot R, Harry GJ, Parker CE, Davis LS, Breyer MD, Waalkes MP, Falck JR, Chen J, Rosenberg RL, Zeldin DC.
  Title
Cytochrome P450 CYP2J9, a new mouse arachidonic acid omega-1 hydroxylase predominantly expressed in brain.
  Journal
J Biol Chem 276:25467-79 (2001)
DOI:10.1074/jbc.M100545200
Reference
  Authors
Tsao CC, Foley J, Coulter SJ, Maronpot R, Zeldin DC, Goldstein JA.
  Title
CYP2C40, a unique arachidonic acid 16-hydroxylase, is the major CYP2C in murine intestinal tract.
  Journal
Mol Pharmacol 58:279-87 (2000)
DOI:10.1124/mol.58.2.279
Reference
PMID:9812980
  Authors
Pfister SL, Spitzbarth N, Nithipatikom K, Edgemond WS, Falck JR, Campbell WB.
  Title
Identification of the 11,14,15- and 11,12, 15-trihydroxyeicosatrienoic acids as endothelium-derived relaxing factors of rabbit aorta.
  Journal
J Biol Chem 273:30879-87 (1998)
DOI:10.1074/jbc.273.47.30879
Related
pathway
oor00591  Linoleic acid metabolism
KO pathway
ko00590   
LinkDB

DBGET integrated database retrieval system